Skip to main content
2025 CNSF Congress Main banner
Final Program


Calendar-of-Events
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation

Industry Supported Session

Lunch 'n Learn: THE CHANGING LANDSCAPE In the Treatment of Alzheimer's Disease

Tuesday, June 10, 2025
12:15 PM – 1:45 PM ET

Audience:

Adult Neurologist, Neuroradiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Intermediate (Practicing Physician)

Learning Format:

Audience response system, Discussion group/peer exchange/user groups, Forum/panels, Lecture/plenary method

CanMEDs Roles:

Medical Expert, Communicator, Collaborator, Health Advocate

The Symposium on Advancements in Alzheimer's Research offers an in-depth exploration of the latest breakthroughs in the understanding, diagnosis, and treatment of Alzheimer's disease. This comprehensive program is designed for clinicians, and healthcare professionals, who are dedicated to combating this debilitating neurological disorder.

This program was developed by the CNSF and Eli Lilly Canada Inc. and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.

Learning Objectives:

  • Articulate the latest scientific and clinical updates on Alzheimer's disease
  • Discuss diagnostic tools and imaging techniques in the identification and treatment of Alzheimers disease
  • Examine the safety and efficacy of new therpaeutic strategies and their efficacy
  • Promote a discussion of collaboration among professionals in the field

Presentations:

  • 12:15 PM – 12:20 PM ET
    Welcome & Introductions

    Faculty: Sara Mitchell

  • 12:20 PM – 12:25 PM ET
    The State of AD in Canada

    Faculty: Sara Mitchell

  • 12:25 PM – 12:40 PM ET
    Diagnosis and Biomarkers

    Faculty: Paolo Vitali

  • 12:40 PM – 12:45 PM ET
    Q&A

    Faculty: Sara Mitchell

    Faculty: Andrew Frank

    Faculty: Paolo Vitali

  • 12:45 PM – 1:00 PM ET
    DMTs - Trial Design and Efficacy

    Faculty: Andrew Frank

  • 1:00 PM – 1:15 PM ET
    Safety and ARIAs

    Faculty: Paolo Vitali

  • 1:15 PM – 1:20 PM ET
    Q&A

    Faculty: Sara Mitchell

    Faculty: Andrew Frank

    Faculty: Paolo Vitali

  • 1:20 PM – 1:35 PM ET
    Canadian Readiness for DMTs

    Faculty: Sara Mitchell

  • 1:35 PM – 1:40 PM ET
    Q&A

    Faculty: Andrew Frank

    Faculty: Sara Mitchell

    Faculty: Paolo Vitali

  • 1:40 PM – 1:45 PM ET
    Conclusion

    Faculty: Sara Mitchell